Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rosiglitazone and Insulin Resistance in Renally Impaired Patients

This study has been terminated.
(it was not possible to recruit new patients anymore)
Sponsor:
Information provided by:
Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT00452166
First received: March 26, 2007
Last updated: September 30, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)